| 000 | 01227 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517141527.0 | ||
| 264 | 0 | _c20170926 | |
| 008 | 201709s 0 0 fre d | ||
| 022 | _a0013-7006 | ||
| 024 | 7 |
_a10.1016/S0013-7006(17)30051-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaurel, M | |
| 245 | 0 | 0 |
_a[How to evaluate side effects in a clinical trial?] _h[electronic resource] |
| 260 |
_bL'Encephale _cDec 2016 |
||
| 300 |
_aS30-S32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xstandards |
| 650 | 0 | 4 |
_aBiogenic Monoamines _xmetabolism |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIatrogenic Disease |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aBelzeaux, R | |
| 700 | 1 | _aAdida, M | |
| 700 | 1 | _aAzorin, J-M | |
| 773 | 0 |
_tL'Encephale _gvol. 42 _gno. 6S _gp. S30-S32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0013-7006(17)30051-9 _zAvailable from publisher's website |
| 999 |
_c26913377 _d26913377 |
||